Joshi, R., Tripathi, M., Gupta, P., Gulati, S
Furthermore, CNS GIPR KO mice have a lower body weight than control mice
Zepbound (tirzepatide) retails for approximately $1,060-1,200/month without insurance
Funding The authors declare that no financial support was received for the research and/or publication of this article
The committee is recommending that Novo Nordisk update the product label for drugs containing semaglutide to include non-arteritic anterior ischemic optic neuropathy as a side effect with a frequency of "very rare." In recent weeks, Novo Nordisk has seen its stock price tumble to multiyear lows, following a July 29 announcement that the Danish drugmaker was slashing its sales and profit projections for 2025